NCT06577025
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06577025
Title A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma (aMMbition)
Acronym aMMbition
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | DEU | BRA | AUS

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
University of California San Francisco San Francisco California 94143 United States Details
University of Iowa Hospital and Clinics Iowa City Iowa 52242 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
Peter MacCallum Cancer Centre Melbourne 3000 Australia Details
The Alfred Hospital Melbourne 3004 Australia Details
Instituto D Or de Pesquisa e Ensino Salvador 41253 190 Brazil Details
Fundacao Antonio Prudente A C Camargo Cancer Center São Paulo 01509 900 Brazil Details
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein São Paulo 05652 900 Brazil Details
Universitaetsklinikum Heidelberg Heidelberg 69120 Germany Details
Universitaetsklinikum Tuebingen Tübingen 72076 Germany Details
Universitatsklinikum Wurzburg Würzburg 97080 Germany Details
Hosp. Univ. 12 de Octubre Madrid 28041 Spain Details
Hosp Clinico Univ de Salamanca Salamanca 37007 Spain Details
Hosp. Univ. Marques de Valdecilla Santander 39008 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field